
S. Korean medical students to end 17-month boycott
South Korean healthcare was plunged into chaos early last year when then-president Yoon Suk Yeol moved to sharply increase medical school admissions, citing an urgent need to boost doctor numbers to meet growing demand in a rapidly ageing society.
The initiative met fierce protest, prompting junior doctors to walk away from hospitals and medical students to boycott their classrooms, with operations cancelled and service provision disrupted nationwide.
The measure was later watered down, and the government eventually offered to scrap it in March this year, after Yoon was impeached over his disastrous declaration of martial law.
"Students have agreed to return to school," said a spokesman for the Korean Medical Association yesterday, adding that it was up to each medical school to decide the schedule for student returns.
The Korean Medical Students' Association said in an earlier statement the students had reached this decision because a continued boycott "could cause the collapse of the fundamentals of medical systems".
Some 8,300 students are expected to return to school, but no specific timeline has been provided.
Prime Minister Kim Min-seok welcomed the decision, calling it a "big step forward" in a Facebook post on Sunday, adding that President Lee Jae Myung was deliberating ways to solve the issue.
In addition to the student boycott, some 12,000 junior doctors went on strike last year — with the vast majority of them still declining to return to work.
The increase in medical school admissions led to a record number of students re-taking the college entrance exam in November in a bid to capitalise on reforms that made it easier to get into coveted majors.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Malaysian Reserve
a day ago
- Malaysian Reserve
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
BELLEVUE, Wash. and SEOUL, South Korea, July 24, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced it has signed a term sheet ('Term Sheet') with Woori IO Co., Ltd. ('WORIO'), a South Korean medical device company developing next-generation noninvasive glucose monitoring technology. The agreement sets forth certain key terms for a strategic acquisition of WORIO by OSR Holdings' Korean affiliate, OSR Holdings Co., Ltd. ('OSRK'). Under the proposed structure, WORIO will become a wholly owned subsidiary of OSRK. Shareholders of WORIO will receive newly issued shares of OSRK through the share exchange and may be eligible to convert them into OSRH common stock traded on NASDAQ, subject to certain conditions including '$10 per OSRH share' WORIO shareholders may convert their OSRK shares into OSRH shares at a fixed exchange ratio of 1 OSRK share = 12.96 OSRH shares, provided that OSRH's stock price reaches $10.00 at least once within three years following the signing of the Term Sheet. If this condition is not met, the parties have agreed to renegotiate in good faith. The agreement includes a 6-month exclusivity period, during which OSRK will conduct confirmatory legal and financial due diligence with a target to complete this transaction within this exclusivity proprietary platform uses near-infrared spectroscopy (NIRS) to measure glucose without needles, sensors, or skin penetration — representing a truly noninvasive alternative to today's continuous glucose monitors (CGMs). Its solution aims to eliminate the burden of pain and daily finger pricks for millions of people with diabetes. According to recent global market research, the blood glucose monitoring devices market is expected to exceed $40 billion by 2030, growing at a CAGR of 8–10%, driven by rising diabetes prevalence and the convergence of medical technology with consumer electronics. Demand for noninvasive and wearable monitoring systems is expected to be a major growth driver. Dexcom, one of the market leaders in minimally invasive CGM which is the current standard of care has more than $32 billion in market capitalization (as of July 11), underscoring the significant commercial potential of advanced glucose monitoring solutions. Noninvasive alternatives hold tremendous promise and are poised to become an integral part of diabetes management in the future. WORIO has completed a proof-of-concept study with the Korea University Hospital (Guro) to validate the accuracy and effectiveness of its prototype devices and the data measured by them, based on which the company plans to enter a larger confirmatory trial to be registered with the Ministry of Food and Drug Safety (MFDS) of Korea for medical device approval pathway. WORIO's noninvasive technology is well positioned to be integrated into wearable glucose monitoring devices such as smart watches — WORIO has been selected by Samsung Electronics' innovative startup program ('C-Lab Outside') in Q1 2025.'We believe this initial milestone with Woori IO aligns strongly with our mission to accelerate breakthrough healthcare innovations with global impact,' said Peter Hwang, CEO of OSRH. 'Woori IO's breakthrough noninvasive glucose monitoring platform, coupled with its high-profile partnership with global companies, puts OSRH in a position to become a first mover in this fast-growing global market.'Following the signing of this Term Sheet, both parties will proceed with due diligence and aim to execute definitive agreements within the 6 months exclusivity period. About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno-oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting-edge research and development. For more information, visit About Woori IO Co., Ltd. Woori IO is a medical device company based in Jeonju, South Korea, focused on the development of noninvasive biosensing solutions. Its proprietary NIRS-based glucose monitoring system enables accurate, pain-free, and user-friendly diabetes management, with strong potential for wearable integration. For more information, visit Contact:Investor RelationsOSR Holdings, IR@ Website:


The Star
a day ago
- The Star
Meta unveils wristband for controlling computers with hand gestures
SAN FRANCISCO: The prototype looks like a giant rectangular wristwatch. But it doesn't tell the time: It lets you control a computer from across the room simply by moving your hand. With a gentle turn of the wrist, you can push a cursor across your laptop screen. If you tap your thumb against your forefinger, you can open an app on your desktop computer. And when you write your name in the air, as if you were holding a pencil, the letters will appear on your smartphone. Designed by researchers at Meta, the tech giant that owns Facebook, Instagram and WhatsApp, this experimental technology reads the electrical signals that pulse through your muscles when you move your fingers. These signals, generated by commands sent from your brain, can reveal what you are about to do even before you do it, as the company detailed in a research paper published Wednesday in the journal Nature . With a little practice, you can even move your laptop cursor simply by producing the right thought. 'You don't have to actually move,' Thomas Reardon, the Meta vice president of research who leads the project, said in an interview. 'You just have to intend the move.' Meta's wristband is part of a sweeping effort to develop technologies that let wearers control their personal devices without touching them. The aim is to provide simpler, quicker and less awkward ways of interacting with everything from laptops to smartphones – and maybe even to develop new digital devices that replace what we all use today. Most of these technologies are years away from widespread use. They typically involve tiny devices surgically implanted in the body, which is a complicated and risky endeavor. These implants are tested solely with disabled people who cannot move their arms and hands, and need new ways of using computers or smartphones. Neuralink, a Silicon Valley startup founded by Elon Musk, aims to implant chips under the skull, beside the brain. Synchron, run by an Australian neurologist, hopes to implant devices inside blood vessels in the neck. These efforts, like those of many other startups, aim to read brain activity directly – an enormously complex process that must be tailored to the individual. Meta is taking a simpler approach. Its technology does not require surgery. Anyone can strap on the device and start using it. Using artificial intelligence techniques, Reardon and his team have identified common electrical signals that appear when a person moves a finger, wrist or thumb. 'This idea – this kind of technology – is not new, it is decades old,' said Dario Farina, a professor of bioengineering at Imperial College, London, who has tested the technology but was not involved in the research. 'The breakthrough here is that Meta has used artificial intelligence to analyse very large amounts of data, from thousands of individuals, and make this technology robust. It now performs at a level it has never reached before.' Meta's wristband uses a technique called electromyography, or EMG, to gather electrical signals from muscles in the forearm. These signals are produced by neurons in the spinal cord – called alpha motor neurons – that connect to individual muscle fibers. Because these neurons connect directly to the muscle fibers, the electrical signals are particularly strong – so strong that they can be read from outside the skin. The signal also moves much faster than the muscles. If a device like Meta's wristband can read the signals, it can type much faster than your fingers. 'We can see the electrical signal before you finger even moves,' Reardon said. EMG has long provided a way for amputees to control prosthetic hands. But technologies that use the technique as a computer interface are only beginning to mature. In 2012, three Canadian entrepreneurs founded a company called Thalmic Labs, which built an armband called Myo that sent simple computer commands using hand gestures. With the swipe of a hand, for instance, you could switch to a new slide in a PowerPoint presentation. But the company discontinued the product several years later. Reardon started similar research after founding a company called Ctrl Labs with two other neuroscientists he had met in a Ph.D. program at Columbia University. In 2019, the startup was acquired by Meta, where it now operates within a research operation called Reality Labs. Although Reardon and his colleagues have been privately demonstrating their technology for years, they are only now beginning to publicly share their work because it is now mature enough for the marketplace. The key development is the use of AI techniques to analyse the EMG signals. After collecting these signals from 10,000 people who agreed to test the prototype, Reardon used a machine learning system called a neural network – the same breed of AI that drives ChatGPT – to identify common patterns in this data. Now, it can look for these same patterns even when a different person is using the device. 'Out of the box, it can work with a new user it has never seen data for,' said Patrick Kaifosh, director of research science at Reality Labs and one of the neuroscientists that founded Ctrl Labs. According to Reardon, who is also known as the founding father of the Internet Explorer web browser at Microsoft, Meta plans to fold the technology into products over the next few years. Last fall, the company demonstrated how its wristband could be used to control an experimental version of its smart glasses, which can take photos, record videos, play music and verbally describe the world around you. Like technologies from Neuralink and Synchron, Meta's wristband could also provide new options for disabled people. Researchers at Carnegie Mellon are testing the wristband with people who have spinal cord injuries, allowing them to use smartphones and computers even though they do not have full use of their arms or hands. Most people with these types of injuries retain the ability to activate at least some of their muscle fibers. This allows the device to read what their brain is trying to do, even though their bodies can't actually make it happen. 'We can see their intention to type,' said Douglas Weber, a professor of mechanical engineering and neuroscience at Carnegie Mellon. In a similar way, Meta's wristband lets you control a computer with the appropriate thought. Merely thinking about a movement is not enough. But if you intend to make a movement, the wristband can pick up on what you aim to do – even if you do not physically move. 'It feels like the device is reading your mind, but it is not,' Reardon said. 'It is just translating your intention. It sees what you are about to do.' When you move your arm or hand or finger, the number of muscle fibers you activate varies depending on how big or how small the movement is. If you practice using the wristband long enough, you can learn to activate a tiny number of fibers without actually moving your fingers. 'We can listen to a single neuron. We are working at the atomic level of the nervous system.' – ©2025 The New York Times Company This article originally appeared in The New York Times.


The Star
2 days ago
- The Star
Let people decide if they want the RM100 aid, says Dr Wee
PETALING JAYA: Those who do not need the RM100 Sumbangan Asas Rahmah (Sara) cash aid should have the option to opt out and let the money be channelled to more critical areas such as education and health, says MCA president Datuk Seri Dr Wee Ka Siong ( pic ). Dr Wee proposed redirecting the money to support public hospitals and award scholarships to deserving students, instead of using it for what he described as blanket populist measures. 'Rather than spending public money on populist measures that may benefit those who don't need it, wouldn't it be better to support those who genuinely do, while also upgrading our healthcare and education systems?' he said in a Facebook post yesterday. Dr Wee suggested a mechanism allowing Malaysians who do not want or need the Sara assistance to voluntarily return it. He said the funds could help reduce the elective surgery backlog for 15,000 patients facing wait times of up to 21 months in government hospitals and provide scholarships for SPM straight-A students, STPM, and matriculation graduates with excellent CGPA results who are still denied places in their preferred university programmes. He also called for the abolition of the Rakan KKM scheme, saying 'it is biased and only benefits patients who can afford to pay more to jump the queue'. Dr Wee added that he believes Prime Minister Datuk Seri Anwar Ibrahim, former prime minister Tun Dr Mahathir Mohamad, Cabinet ministers, MPs and assemblymen would also be willing to forgo the RM100 aid. 'I will be the first to contribute mine. A win-win solution – the people get to choose, and the government wins too!' he said. Yesterday, Anwar announced that every Malaysian aged 18 and above will receive a one-off RM100 credit via MyKad starting Aug 31 under the Sara initiative.